• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经调节素 U(NMU)调节成骨细胞分化和活性。

Neuromedin U (NMU) regulates osteoblast differentiation and activity.

机构信息

Division of Biomedical Science, Marian University College of Osteopathic Medicine, Indianapolis, IN, USA; Bone & Mineral Research Group, Marian University, Indianapolis, IN, USA.

Department of Biology, The University of Scranton, Scranton, PA, USA.

出版信息

Biochem Biophys Res Commun. 2020 Apr 16;524(4):890-894. doi: 10.1016/j.bbrc.2020.02.003. Epub 2020 Feb 11.

DOI:10.1016/j.bbrc.2020.02.003
PMID:32057362
Abstract

Osteoporosis is a disease of low bone mass that places individuals at enhanced risk for fracture, disability, and death. Osteoporosis rates are expected to rise significantly in the coming decades yet there are limited pharmacological treatment options, particularly for long-term management of this chronic condition. The drug development pipeline is relatively bereft of new strategies, causing an urgent and unmet need for developing new strategies and targets for treating osteoporosis. Here, we examine a lesser-studied bone remodeling pathway, Neuromedin U (NMU), which is expressed in the bone microenvironment along with its cognate receptors NMU receptor 1 (NMUR1) and 2 (NMUR2). We independently corroborate a prior report that global loss of NMU expression leads to high bone mass and test the hypothesis that NMU negatively regulates osteoblast differentiation. Consistent with this, in vitro studies reveal NMU represses osteoblastic differentiation of osteogenic precursors but, in contrast, promotes osteoblastic marker expression, proliferation and activity of osteoblast-like cells. Phospho-profiling arrays were used to detail differential signaling outcomes that may underlie the opposite responses of these cell types. Collectively, our findings indicate that NMU exerts cell-type-specific responses to regulate osteoblast differentiation and activity.

摘要

骨质疏松症是一种低骨量疾病,使个体面临更高的骨折、残疾和死亡风险。预计未来几十年骨质疏松症的发病率将显著上升,但治疗这种慢性疾病的药物选择有限,特别是长期治疗。药物研发管道相对缺乏新策略,因此迫切需要开发治疗骨质疏松症的新策略和靶点。在这里,我们研究了一个研究较少的骨重塑途径,即神经肽 U(NMU),它与同源受体 NMU 受体 1(NMUR1)和 2(NMUR2)一起在骨微环境中表达。我们独立证实了之前的一份报告,即 NMU 的全局缺失表达导致高骨量,并检验了 NMU 负向调节成骨细胞分化的假设。与这一假设一致的是,体外研究表明 NMU 抑制成骨前体细胞的成骨细胞分化,但相反,促进成骨样细胞的成骨细胞标志物表达、增殖和活性。磷酸化谱分析用于详细描述可能解释这些细胞类型相反反应的差异信号转导结果。总的来说,我们的研究结果表明,NMU 对成骨细胞分化和活性具有细胞类型特异性的反应。

相似文献

1
Neuromedin U (NMU) regulates osteoblast differentiation and activity.神经调节素 U(NMU)调节成骨细胞分化和活性。
Biochem Biophys Res Commun. 2020 Apr 16;524(4):890-894. doi: 10.1016/j.bbrc.2020.02.003. Epub 2020 Feb 11.
2
NMUR1 in the NMU-Mediated Regulation of Bone Remodeling.NMU介导的骨重塑调节中的NMUR1
Life (Basel). 2021 Sep 29;11(10):1028. doi: 10.3390/life11101028.
3
Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.鸡中神经调节素 U(NMU)、神经调节素 S(NMS)及其受体(NMUR1、NMUR2)的特性。
Peptides. 2018 Mar;101:69-81. doi: 10.1016/j.peptides.2017.12.022. Epub 2017 Dec 27.
4
Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform.神经介素U通过NMU受体2亚型直接刺激培养的大鼠颅骨成骨样细胞生长。
Int J Mol Med. 2008 Sep;22(3):363-8.
5
Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.鉴定神经介素U受体2剪接变体并确定其在体外信号调节和肿瘤发生中的作用。
PLoS One. 2015 Aug 28;10(8):e0136836. doi: 10.1371/journal.pone.0136836. eCollection 2015.
6
Neuromedin U suppresses insulin secretion by triggering mitochondrial dysfunction and endoplasmic reticulum stress in pancreatic β-cells.神经调节素 U 通过触发胰腺β细胞线粒体功能障碍和内质网应激来抑制胰岛素分泌。
FASEB J. 2020 Jan;34(1):133-147. doi: 10.1096/fj.201901743R. Epub 2019 Nov 19.
7
Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.神经介素U在乳腺癌中的致癌特性与NMUR2表达相关,涉及与WNT信号通路成员的相互作用。
Oncotarget. 2017 May 30;8(22):36246-36265. doi: 10.18632/oncotarget.16121.
8
Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2.卵巢调节神经调节素 U 及其在卵巢中的局部作用,通过神经调节素 U 受体 2 介导。
Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E800-9. doi: 10.1152/ajpendo.00548.2012. Epub 2013 Feb 19.
9
Cloning and expression patterns of neuromedin U and its receptors in pigs.猪的神经调节素 U 及其受体的克隆与表达模式。
Neuropeptides. 2017 Aug;64:47-60. doi: 10.1016/j.npep.2017.04.003. Epub 2017 Apr 6.
10
Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.外周给予神经调节素 U 受体 2 选择性激动剂对肥胖小鼠摄食量和体重的影响。
Int J Obes (Lond). 2017 Dec;41(12):1790-1797. doi: 10.1038/ijo.2017.176. Epub 2017 Jul 31.

引用本文的文献

1
Examining the Role of Hypothalamus-Derived Neuromedin-U (NMU) in Bone Remodeling of Rats.研究下丘脑源性神经介素U(NMU)在大鼠骨重塑中的作用。
Life (Basel). 2023 Mar 31;13(4):918. doi: 10.3390/life13040918.
2
Bones and Hormones: Interaction between Hormones of the Hypothalamus, Pituitary, Adipose Tissue and Bone.骨骼与激素:下丘脑、垂体、脂肪组织与骨骼的激素之间的相互作用。
Int J Mol Sci. 2023 Apr 6;24(7):6840. doi: 10.3390/ijms24076840.
3
NMUR1 in the NMU-Mediated Regulation of Bone Remodeling.NMU介导的骨重塑调节中的NMUR1
Life (Basel). 2021 Sep 29;11(10):1028. doi: 10.3390/life11101028.
4
Neuromedins NMU and NMS: An Updated Overview of Their Functions.神经调节素 NMU 和 NMS:功能的最新概述。
Front Endocrinol (Lausanne). 2021 Jul 1;12:713961. doi: 10.3389/fendo.2021.713961. eCollection 2021.